IPCP Project

Category: Research

Project Title

Demonstrating the effective delivery of daily oral HIV pre-exposure prophylaxis (PrEP) as part of an HIV combination prevention intervention among young women at high HIV risk, female sex workers and men who have sex with men in Kenya (IPCP-Kenya)

 Project Objectives

  1. To validate tools for risk identification and indications for PrEP initiation among YW at high HIV risk
  2. To document PrEP side effects and adverse events among MSM, FSW and  YW at high HIV risk
  3. To monitor safe uptake of PrEP among pregnant women
  4. To determine acceptability of HIV re-testing among MSM, FSW and YW at high HIV risk
  5. Develop tools, strategies and messaging to promote uptake and sustained adherence to PrEP as part of a combination prevention package.
  6. To demonstrate effective delivery of oral HIV PrEP as part of a combined prevention package among MSM, FSWs and YW at high risk of HIV

Target Population

This project is targeting individuals that are considered to be at high risk of HIV acquisition in Kenya. These are:

  • Men who have sex with men (MSM)
  • Female sex workers (FSW)
  • Young women and girls aged 15 – 29 years (YW)

The project aims to recruit a total of 2100 individuals considered to be at high risk of HIV acquisition. This includes 450 men who have sex with men (MSM), 800 female sex workers (FSW) and 850 young women (YW).

Implementing Sites

This project is being implemented in 5 sites in Kenya including LVCT Health Tivoli VCT site (targeting MSM& female sex workers), LVCT Health Nairobi CBD site (targeting MSM), Korogocho Health Centre (targeting young women aged 15-29), Homa Bay County Hospital (targeting young women aged 15-29) and SWOP City clinic (targeting female sex workers). 

Project Duration

Participants who enrol into this project will receive a range of HIV prevention services of their choice available at the project site, including HIV PrEP with guidance from the project staff. They will be given a daily pill of Truvada (PrEP medication) for a period of 12 months. The pregnant mothers who agree to take part in the study will also be followed up 12 months post-partum (after giving birth).

Eligibility

For participants to be enrolled into the project, they have to be eligible according to the criteria that have been set by the project. The following will therefore be done so as to ascertain eligibility:

  • HTC (HIV Testing and Counselling)
  • Risk Screening
  • Urine pregnancy test (for women)
  • Creatinine level test
  • STI syndromic screening and management
  • Gonorrhoea test

FAQs
Principal Investigators
Contacts for Recruitment Purposes
Downloads

 

 

 

Online Library

Media Center